Form 4: CalciMedica Chief Medical Officer Acquires Stock Options
SEC Form 4 Filing
Sudarshan Hebbar, Chief Medical Officer of CalciMedica, acquired stock options for 82,500 shares on August 27, 2024.
Summary
- On August 27, 2024, Sudarshan Hebbar, the Chief Medical Officer of CalciMedica, acquired options to purchase 82,500 shares of common stock at an exercise price of $4.16.
- The options vest in equal monthly installments over a four-year period following March 28, 2024, with 1/48th of the shares vesting each month.
- The options expire on August 26, 2034.
- Following the transaction, Hebbar directly owns options for 82,500 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of stock option grants. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider activity.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings provide transparency into insider transactions and can be scrutinized by investors for signals about the company's prospects.
Stakeholder Impact
- Shareholders may view this as a positive sign if they believe the executive's increased stake aligns their interests with the company's success.
Key Dates
| Date | Description |
|---|---|
| March 28, 2024 | Start date for monthly vesting of stock options. |
| August 27, 2024 | Date of stock option grant to Sudarshan Hebbar. |
| August 26, 2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.